2483.8000 27.90 (1.14%)
NSE Jan 02, 2026 15:31 PM
Volume: 27,469
 

2483.80
1.14%
Sharekhan
Volume growth sustains; Low input cost and efficiencies led to margin expansion: GSK Consumer reported strong results in Q4FY2019, with broad-based growth across products and channels. Revenue grew by 9%, driven by 6.3% volume growth. Business auxiliary income rose by 20% y-o-y, led by double-digit growth across all products. Unlike other FMCG companies, GSK...
GlaxoSmithKline has lost -24.59% in the last 6 Months
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended